{
    "Trade/Device Name(s)": [
        "CrAg Lateral Flow Assay",
        "Cryptococcal Antigen Lateral Flow Assay",
        "CrAg LFA"
    ],
    "Submitter Information": "Immuno-Mycologics, Inc.",
    "510(k) Number": "K112422",
    "Predicate Device Reference 510(k) Number(s)": [
        "K102286"
    ],
    "Regulatory Class": "Class II",
    "Product Code(s)": [
        "GMD"
    ],
    "Summary Letter Date": "March 26, 2012",
    "Summary Letter Received Date": "March 27, 2012",
    "Submission Date": "",
    "Regulation Number(s)": [
        "21CFR866.3165"
    ],
    "Regulation Name(s)": [
        "Cryptococcal antigen lateral flow assay"
    ],
    "Analyte Class(es)": [
        "mycology",
        "microbiology"
    ],
    "Analyte(s)": [
        "Capsular polysaccharide antigens of Cryptococcus species complex (Cryptococcus neoformans and Cryptococcus gattii)"
    ],
    "Specimen Type(s)": [
        "Serum",
        "Cerebrospinal fluid (CSF)"
    ],
    "Specimen Container(s)": [
        "Test tube",
        "Microtiter plate"
    ],
    "Instrument(s)/Platform(s)": [],
    "Method(s)/Technology(ies)": [
        "Immunochromatographic assay",
        "Lateral flow assay",
        "Dipstick sandwich assay"
    ],
    "Methodologies": [
        "Immunochromatographic testing",
        "Lateral flow"
    ],
    "Submission Type(s)": [
        "Assay",
        "Test"
    ],
    "Document Summary": "FDA 510(k) summary for IMMY CrAg Lateral Flow Assay for qualitative and semi-quantitative detection of Cryptococcus antigens in serum and CSF.",
    "Indications for Use Summary": "Qualitative or semi-quantitative detection of capsular polysaccharide antigens of Cryptococcus species complex in serum and CSF to aid in diagnosis of cryptococcosis.",
    "fda_folder": "Microbiology"
}